IMM PE Set to Acquire CGBio, Strengthening Korea’s Regenerative Spine Platform (opens in new tab)

IMM Private Equity is reportedly close to acquiring a controlling stake in CGBio Co., the Korean regenerative medicine company affiliated with Daewoong Pharmaceutical, in a transaction that could value the deal at up to $730 million. According to Korean media reports, IMM PE may acquire as much as 80% of CGBio, following earlier reports that […]